NCT04825171View on ClinicalTrials.gov

Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Anxiety Symptoms
Interventions
DRUG

Bryophyllum 50 % Chewing Tablets

Each 350 mg tablet corresponds to 170 mg of leave press juice from Bryophyllum pinnatum, dried down to 17 mg by mixing with lactose; 100 mg dried BP matter in 1 g.

Trial Locations (1)

4144

Klinik Arlesheim, Arlesheim

All Listed Sponsors
lead

Markus Schlemmer

OTHER

NCT04825171 - Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability | Biotech Hunter | Biotech Hunter